Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease
Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;
Ann Hepatol. 2023;28:
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
Louise Torres; Alice Schuch; Larisse Longo; Bruna Bressan Valentini; Gabriela Schneider Galvão; Eduardo Luchese; Carlos Pinzon; Rodrigo Bartels; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28: